by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
The Benefit of Brentuximab Vedotin and Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Single-Center Retrospective Study Diana-Marina FORTOES, Elena NICORICI, Cosmin MINCIUNA Andrei CIANGA, Ramona TIMOFTE, Amalia TITIEANU, Elena DOLACHI-PELIN, Ion...
by Catalin | Jun 25, 2025 | 2025 vol. 3 issue 2
Clinical Diversity and Treatment Outcomes in IgM Monoclonal Gammopathy Associated with Cold Agglutinin Disease and Cryoglobulinemia: A Single Center Study Larisa ZIDARU, Sinziana BARBU, Ruxandra DRAGHICI, Sebastian Nicolae TIMOTEI, Daniel CORIU, Sorina Nicoleta...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Caplacizumab in the Treatment of Patients with Recurrent Thrombotic Thrombocytopenic Purpura (TTP) Mihaela-Sabrina HERDEA, Adela-Sara IONESCU, Oana PATRINOIU, Mihaela ANDREESCU We report two cases of recurrent thrombotic thrombocytopenic purpura, both patients without...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Evaluation of the Benefit of Ropeginterferon Treatment in Patients with Polycythemia Vera Diana GRASU, Viola Maria POPOV, Mirela VOICU, Mihaela POPESCU, Oana PATRINOIU, Felicia MIHAI, Geanina OFITERU, Meilin OMER, Mihaela ANDREESCU Results: Twenty-three patients (15...
by Catalin | Mar 28, 2025 | 2025 vol. 3 issue 1
Is Quality of Life Better in Hemophilia Patients with or Without Prophylactic Treatment? Using Haemo-SYM to Answer the Question Catalina GURAN, Mieta-Gabriela HATEGAN, Dacian Nicolae OROS, Despina CALAMAR-POPOVICI, Marioara IONITA HORTENSIA, Claudiu IONITA, Florica...